tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB
Holding INMB?
Track your performance easily

Inmune Bio (INMB) Income Statement

332 Followers

Inmune Bio Income Statement

Last quarter (Q3 2024), Inmune Bio's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Inmune Bio's net income was $-12.09M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 42.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K-
Cost of Revenue
------
Gross Profit
$ 42.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K-
Operating Expense
$ 19.53M$ 29.90M$ 26.32M$ 29.33M$ 12.24M$ 7.76M
Operating Income
$ -41.55M$ -29.74M$ -25.95M$ -29.15M$ -12.23M$ -7.76M
Net Non Operating Interest Income Expense
$ 566.93M$ -2.28M$ -2.01M$ -985.00K-$ 77.69K
Other Income Expense
$ 74.00K$ -267.00K$ -1.35M$ 2.00K$ -129.00K$ -77.69K
Pretax Income
$ -19.34M$ -30.01M$ -27.30M$ -30.34M$ -12.10M$ -7.68M
Tax Provision
$ -6.30M$ -6.30M$ -5.73M$ -6.38M$ -2.54M$ 159.15K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -41.25M$ -30.01M$ -27.30M$ -30.34M$ -12.10M$ -7.68M
Basic EPS
$ -2.18$ -1.67$ -1.52$ -1.88$ -1.01-
Diluted EPS
$ -2.18$ -1.67$ -1.52$ -1.88$ -1.01$ -0.75
Basic Average Shares
$ 75.54M$ 17.98M$ 17.93M$ 16.13M$ 11.99M$ 10.27M
Diluted Average Shares
$ 75.54M$ 17.98M$ 17.93M-$ 11.99M$ 10.27M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.53M$ 29.90M$ 26.32M$ 29.33M$ 12.24M$ 7.76M
Net Income From Continuing And Discontinued Operation
$ -41.25M$ -30.01M$ -27.30M$ -30.34M$ -12.10M$ -7.68M
Normalized Income
$ -25.53M$ -36.31M-$ -36.72M--
Interest Expense
------
EBIT
$ -19.14M$ -29.74M$ -25.95M$ -29.15M$ -12.23M$ -7.68M
EBITDA
$ -19.07M$ -29.74M$ -25.95M$ -29.15M$ -12.23M$ -7.68M
Currency in USD

Inmune Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis